Clinical outcomes of mechanical thrombectomy following intravenous administration of recombinant tissue-type plasminogen activator for basilar artery occlusion
- PMID: 32247170
- DOI: 10.1016/j.clineuro.2020.105796
Clinical outcomes of mechanical thrombectomy following intravenous administration of recombinant tissue-type plasminogen activator for basilar artery occlusion
Abstract
Objective: Mechanical thrombectomy (MT) following intravenous administration of recombinant tissue-type plasminogen activator (IV-rt-PA) is considered an effective treatment for the occlusion of the internal carotid artery or the M1 segment of the middle cerebral artery. However, its efficacy in treating basilar artery (BA) occlusion is still unclear. In order to evaluate the efficacy of MT in treating BA occlusion, we aimed to analyzed the clinical outcomes of those patients who had undergone MT following IV-rt-PA administration.
Patients and methods: We retrospectively analyzed the clinical outcomes of 11 patients with BA occlusion who had undergone MT following IV-rt-PA administration between January 1, 2015, and March 31, 2019.
Results: The patients consisted of 8 men and 3 women. The mean (±standard deviation) age was 73 ± 9.4 years. Stroke subtypes were found to be atherothrombosis in 2 patients, cardiogenic embolism in 6, arterial dissection in 1, and an unknown cause in 2. The median pretreatment scores were 9 on the Glasgow Coma Scale (GCS) and 25 on the National Institutes of Health Stroke Scale. The time elapsed from onset of the stroke to reperfusion was 281 min. Successful reperfusion, characterized by a modified Thrombolysis in Cerebral Infarction grade ≥ 2b, was achieved in all patients. The 3-month outcomes were good [modified Rankin Scale (mRS) 0-2] in 5 patients and poor (mRS 3-6) in 6 patients. The pretreatment median GCS scores were significantly higher in patients with a good outcome compared to that in those with a poor outcome with scores of 11 and 7.5, respectively (P = 0.044). The receiver operating characteristic (ROC) curve analysis showed that the optimal cut-off score on the GCS was 9.5 [area under the curve (AUC), 0.867; sensitivity, 0.8; specificity, 1.0]. Complications occurred in 1 patient with arterial dissection who had developed a subarachnoid hemorrhage and later died.
Conclusion: The results of the present study suggests that the pretreatment GCS score might affect the clinical outcomes in patients with BA occlusion who underwent MT following IV-rt-PA therapy.
Keywords: Basilar artery occlusion; Glasgow Coma Scale; Ischemic stroke; Mechanical thrombectomy; Outcome; Recombinant tissue-type plasminogen activator.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Similar articles
-
Mechanical Thrombectomy for Acute Basilar Artery Occlusion in Early Therapeutic Time Window.Cerebrovasc Dis. 2017;44(3-4):217-224. doi: 10.1159/000479939. Epub 2017 Aug 19. Cerebrovasc Dis. 2017. PMID: 28848166
-
Risk Factors for Distal Clot Migration during Mechanical Thrombectomy of Anterior Circulation Large Vessel Occlusion.Cerebrovasc Dis. 2020;49(2):185-191. doi: 10.1159/000507341. Epub 2020 Mar 30. Cerebrovasc Dis. 2020. PMID: 32224607
-
Mechanical thrombectomy with the Solitaire device in acute basilar artery occlusion.J Neurointerv Surg. 2014 Apr 1;6(3):200-4. doi: 10.1136/neurintsurg-2012-010629. Epub 2013 May 4. J Neurointerv Surg. 2014. PMID: 23645572
-
Treatment of acute basilar artery occlusion: Systematic review and meta-analysis.Neurol Neurochir Pol. 2017 Nov-Dec;51(6):486-496. doi: 10.1016/j.pjnns.2017.07.012. Epub 2017 Aug 1. Neurol Neurochir Pol. 2017. PMID: 28823413
-
[Prospects of thrombolytic therapy for acute ischemic stroke].Brain Nerve. 2009 Sep;61(9):1003-12. Brain Nerve. 2009. PMID: 19803399 Review. Japanese.
Cited by
-
Vascular tortuosity in endovascular mechanical thrombectomy.Brain Circ. 2021 Mar 30;7(1):3-7. doi: 10.4103/bc.bc_5_21. eCollection 2021 Jan-Mar. Brain Circ. 2021. PMID: 34084969 Free PMC article. Review.
-
Decision-making strategies for reperfusion therapies: navigating through stroke trials gaps.Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):60-71. doi: 10.1590/0004-282X-ANP-2022-S123. Arq Neuropsiquiatr. 2022. PMID: 35976313 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources